SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rande Is who wrote (28463)6/25/2000 1:14:00 AM
From: Mike McFarland  Read Replies (2) of 57584
 
Sounds like you've been keeping tabs on the genome news
lately. I saw Venter on the Charlie Rose show on Monday,
Collins was a good interview on Tuesday...taped the rest
of the week.

I'm not much for the billion dollar genomics stocks, kinda
hard to assess what they're up to. What I am excited about
is watching the old plain vanilla biotechs tap into this
information--if the information is useful they'll know
how to mine it for all it is worth. On the other hand,
I own several biotechs that probably have no interest in
genome data. What they probably need is very specific
gene expresson data. Just throwing some thoughts out there.

In your Ragingbull post, you wrote
We need to watch for alliances, mergers and other
consolidations that could set up a formidable opponent to
the tradtional chemical drug makers.

I think the most recent was that AVE/MLNM deal. Wow, to
think that Hoechst could simply have bought out Millennium
a couple years ago for that kind of money! (although they
might not have sold out)

Although the genome stocks look richly priced to me, who
the hell am I to judge? And you could say that if companies
like CRA start pulling billion dollar drugs out of the
genome the valuation is okay. And it isn't as if Celera's
business can be replaced by a bootlegged DVD of sequence--
they're supposed to be adding value, using some sort of
mathmatical algorithms to identify the genes where are
not yet known, right? Fill us in Rande, I don't follow CRA.

I do own some Genset, but it has lagged the group badly for
no reason that I can see other than it doesn't do a lot of
trading volume and hasn't had the sexy news flow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News